

Cover Story
COVID-19 & CancerFree
By Matthew Bin Han Ong
NCI’s Frederick National Laboratory for Cancer Research has launched three initiatives focused on SARS-CoV-2.
COVID-19 Updates


In Brief
Clinical Roundup
Drugs & Targets
Trending Stories
- GRAIL to use new study results to seek FDA approval of Galleri MCD test
- Duke brain cancer researcher Kyle Walsh named director of NIEHS
- Trump cuts IVF drug deal with Merck in exchange for tariff exemption
- Cliff Hudis on how AI in cancer care is “inevitable”—and ASCO is working to make it safer
- Science advocates organize march in DC to demand impeachment of RFK Jr.
- Lazarex Cancer Foundation set to close its doors Dec. 31
Can health nonprofits survive in the current environment?




















